Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection

The outbreak of COVID-19 caused by SARS-CoV-2 has resulted in more than 50 million confirmed cases and over 1 million deaths worldwide as of November 2020. Currently, there are no effective antivirals approved by the Food and Drug Administration to contain this pandemic except the antiviral agent re...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Proceedings of the National Academy of Sciences - PNAS Ročník 118; číslo 5
Hlavní autoři:	Jan, Jia-Tsrong, Cheng, Ting-Jen Rachel, Juang, Yu-Pu, Ma, Hsiu-Hua, Wu, Ying-Ta, Yang, Wen-Bin, Cheng, Cheng-Wei, Chen, Xiaorui, Chou, Ting-Hung, Shie, Jiun-Jie, Cheng, Wei-Chieh, Chein, Rong-Jie, Mao, Shi-Shan, Liang, Pi-Hui, Ma, Che, Hung, Shang-Cheng, Wong, Chi-Huey
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 02.02.2021
Témata:	Adult Animals Antiviral Agents - chemistry Antiviral Agents - pharmacology Antiviral Agents - therapeutic use Chlorocebus aethiops COVID-19 - drug therapy COVID-19 - epidemiology COVID-19 - virology Cricetinae Disease Models, Animal Drug Repositioning - methods Female Humans Male Pandemics Plant Extracts - pharmacology SARS-CoV-2 - drug effects SARS-CoV-2 - genetics Vero Cells SARS-CoV-2 cell-based and animal studies drug repurposing antiviral
ISSN:	1091-6490, 1091-6490
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!